Docoh
Loading...

NSPR InspireMD

News

From Benzinga Pro
4 Penny Stocks Insiders Are Buying
3 Dec 21
Long Ideas, News, Penny Stocks, Small Cap, Insider Trades, Pre-Market Outlook, Markets, Trading Ideas
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
12 Health Care Stocks Moving In Wednesday's After-Market Session
1 Dec 21
Movers
Gainers Hoth Therapeutics (NASDAQ:HOTH) shares moved upwards by 6.08% to $0.86 during Wednesday's after-market session. The company's market cap stands at $20.6 million.
5 Penny Stocks Insiders Are Buying
29 Nov 21
Long Ideas, News, Penny Stocks, Insider Trades, Pre-Market Outlook, Markets, Trading Ideas
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
5 Penny Stocks Insiders Are Buying
24 Nov 21
Long Ideas, News, Penny Stocks, Small Cap, Insider Trades, Pre-Market Outlook, Markets, Trading Ideas
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
12 Health Care Stocks Moving In Tuesday's After-Market Session
23 Nov 21
Movers
Gainers
CORRECTION: InspireMD, Inc. Common Stock Q3 EPS $(0.53) Beats $(0.82) Estimate, Sales $1.07M Miss $1.20M Estimate
9 Nov 21
Earnings, News
InspireMD, Inc. Common Stock (AMEX:NSPR) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.82) by 35.37 percent. This is a 783.33 percent decrease over losses of $(0.06) per
Earnings Scheduled For November 9, 2021
9 Nov 21
Earnings, M&A, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter. • KT (NYSE:KT) is projected to report earnings for its third quarter.
InspireMD Announces Publication Of 12-Month Results Of CGuard™ EPS SIBERIA Trial In Journals Of The American College of Cardiology: Cardiovascular Interventions
3 Nov 21
News
InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced that results from the
50 Biggest Movers From Yesterday
14 Oct 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.
39 Stocks Moving In Wednesday's Mid-Day Session
13 Oct 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.
Mid-Morning Market Update: Markets Mixed; JPMorgan Posts Upbeat Earnings
13 Oct 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Following the market opening Wednesday, the Dow traded down 0.36% to 34,254.62 while the NASDAQ rose 0.27% to 14,505.47. The S&P also fell, dropping 0.07% to 4,347.49.
InspireMD Reports Received Reimbursement Approval For CGuard Embolic Prevention System From French National Authority For Health
13 Oct 21
Biotech, News, FDA, General
InspireMD, Inc. (NASDAQ:NSPR), a global developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announced that its CGuard
InspireMD Granted Canadian Patent Titled 'INTRAVASCULAR ANEURYSM TREATMENT DEVICE AND METHODS'
15 Sep 21
News, Legal
https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/3013758/summary.html

Press releases

From Benzinga Pro
InspireMD Announces Publication of 12-Month Results of CGuard™ EPS SIBERIA Trial in Journals of the American College of Cardiology: Cardiovascular Interventions
3 Nov 21
Health Care, Analyst Ratings, Press Releases
TEL AVIV, Israel, Nov. 03, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery
InspireMD to Report Third Quarter 2021 Financial Results on November 9, 2021 and Provide Corporate Business Update
26 Oct 21
News, Press Releases
TEL AVIV, Israel, Oct. 26, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and
InspireMD Receives Reimbursement Approval for CGuard™ Embolic Prevention System from the French National Authority for Health
13 Oct 21
Press Releases
TEL AVIV, Israel, Oct. 13, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), a global developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD)
Increasing Incidences of Cardiac Arrhythmias Raising Demand for Electrophysiology Medical Devices
21 Sep 21
Small Cap, Opinion, Press Releases
PALM BEACH, Fla., Sept. 21, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary Growing prevalence of cardiovascular disorders (CVDs) globally is anticipated to substantially increase in the upcoming years.
BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors
21 Sep 21
Health Care, Press Releases
Westport, CT, Sept. 21, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ:BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing